Jiarui Yao

1.1k total citations
55 papers, 767 citations indexed

About

Jiarui Yao is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jiarui Yao has authored 55 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 16 papers in Molecular Biology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Jiarui Yao's work include Lymphoma Diagnosis and Treatment (14 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Jiarui Yao is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Jiarui Yao collaborates with scholars based in China, United States and Austria. Jiarui Yao's co-authors include Yuankai Shi, Xiaohong Han, Ming Yang, Wen Tan, Dongxin Lin, Yongli Guo, Changqing Zeng, Qingrun Zhang, Xuemei Zhang and Sufang Ma and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Jiarui Yao

50 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiarui Yao China 12 323 277 196 130 120 55 767
Jan Kornafel Poland 16 246 0.8× 411 1.5× 182 0.9× 90 0.7× 81 0.7× 73 832
Kirsten Kübler Germany 15 344 1.1× 339 1.2× 276 1.4× 73 0.6× 79 0.7× 27 924
Anne Perdrix France 15 290 0.9× 199 0.7× 90 0.5× 116 0.9× 51 0.4× 50 933
Dalin Li China 15 210 0.7× 296 1.1× 211 1.1× 110 0.8× 62 0.5× 27 650
Donglin Sun China 16 277 0.9× 152 0.5× 114 0.6× 86 0.7× 44 0.4× 42 631
Sunita Badola United States 9 207 0.6× 233 0.8× 135 0.7× 131 1.0× 65 0.5× 16 729
Nancy Patten United States 11 216 0.7× 208 0.8× 107 0.5× 123 0.9× 196 1.6× 18 635
Vivian Weiß United States 17 188 0.6× 305 1.1× 155 0.8× 83 0.6× 62 0.5× 55 714
Yu Zeng China 16 208 0.6× 176 0.6× 91 0.5× 185 1.4× 102 0.8× 47 672

Countries citing papers authored by Jiarui Yao

Since Specialization
Citations

This map shows the geographic impact of Jiarui Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiarui Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiarui Yao more than expected).

Fields of papers citing papers by Jiarui Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiarui Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiarui Yao. The network helps show where Jiarui Yao may publish in the future.

Co-authorship network of co-authors of Jiarui Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Jiarui Yao. A scholar is included among the top collaborators of Jiarui Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiarui Yao. Jiarui Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tang, Le, Jiarui Yao, Yiming Zhu, et al.. (2025). Pembrolizumab with Chemotherapy for Patients with Recurrent or Metastatic Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma: A Prospective Phase ll Study. Clinical Cancer Research. 31(9). 1636–1643. 1 indexed citations
3.
4.
Nie, He, et al.. (2025). The real cost channel and the Phillips Curve for China. Economics Letters. 247. 112160–112160. 1 indexed citations
5.
Yao, Jiarui, Meng Yuan, Congyu Wang, et al.. (2025). GINS4 silencing mediates hepatocellular cancer cell proliferation, cycle and ferroptosis through POLE2. Cellular Signalling. 131. 111742–111742. 2 indexed citations
6.
7.
Dai, Liyuan, Shasha Wang, Zhishang Zhang, et al.. (2024). A Novel IgG–IgM Autoantibody Panel Enhances Detection of Early-stage Lung Adenocarcinoma from Benign Nodules. Genomics Proteomics & Bioinformatics. 22(6).
8.
9.
Wang, Shasha, Xuezhi Hao, Liyuan Dai, et al.. (2024). Longitudinal plasma proteomic profiling of EML4-ALK positive lung cancer receiving ALK-TKIs therapy. Lung Cancer. 189. 107503–107503. 3 indexed citations
10.
Zhang, Zhishang, Le Tang, Jiarui Yao, et al.. (2023). High-Throughput Peptide Arrays Identify Potential Diagnostic Autoantibody Signatures in Early-Stage Lung Adenocarcinoma. Cancer Epidemiology Biomarkers & Prevention. 32(5). 726–738. 1 indexed citations
11.
12.
Zhou, Yu, Shasha Wang, Yunxia Tao, et al.. (2021). Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapy. Journal of Translational Medicine. 19(1). 399–399. 8 indexed citations
13.
14.
Wang, Shuai, Xiaohong Han, Jianfei Wang, Jiarui Yao, & Yuankai Shi. (2014). Antitumor Effects of a Novel Chromosome Region Maintenance 1 (CRM1) Inhibitor on Non-Small Cell Lung Cancer Cells In Vitro and in Mouse Tumor Xenografts. PLoS ONE. 9(3). e89848–e89848. 29 indexed citations
15.
Han, Xiaohong, Jianfei Wang, Yinchen Shen, et al.. (2014). CRM1 as a new therapeutic target for non-Hodgkin lymphoma. Leukemia Research. 39(1). 38–46. 19 indexed citations
16.
Yao, Jiarui, Li Liu, & Ming Yang. (2013). Interleukin-23 receptor genetic variants contribute to susceptibility of multiple cancers. Gene. 533(1). 21–25. 19 indexed citations
17.
Ma, Li, Hongying Yang, Jia Li, et al.. (2012). Relationship between serum HER2 extracellular domain levels, tissue HER2 expression, and clinico-pathological parameters in early stage breast cancer.. PubMed. 125(22). 4104–10. 8 indexed citations
18.
Guo, Yong‐Xin, Xuan Zhang, Ming Yang, et al.. (2010). Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancer. Journal of Medical Genetics. 47(9). 616–622. 39 indexed citations
19.
Sun, Tong, Yifeng Zhou, Ming Yang, et al.. (2008). Functional Genetic Variations in Cytotoxic T-Lymphocyte Antigen 4 and Susceptibility to Multiple Types of Cancer. Cancer Research. 68(17). 7025–7034. 138 indexed citations
20.
Sun, Tong, Yang Gao, Wen Tan, et al.. (2007). A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nature Genetics. 39(5). 605–613. 218 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Kornafel Breakdown of academic impact, for papers by Kirsten Kübler Breakdown of academic impact, for papers by Anne Perdrix Breakdown of academic impact, for papers by Dalin Li Breakdown of academic impact, for papers by Donglin Sun Breakdown of academic impact, for papers by Sunita Badola Breakdown of academic impact, for papers by Nancy Patten Breakdown of academic impact, for papers by Vivian Weiß Breakdown of academic impact, for papers by Yu Zeng
Rankless by CCL
2026